Company Filing History:
Years Active: 2016-2018
Title: **The Innovative Journey of Inventor Said Oumouch**
Introduction
Said Oumouch, an inventive mind based in Mulhouse, France, has made significant contributions to the field of pharmaceuticals through his innovative work on macrocyclic compounds. With a total of three patents to his name, Oumouch's research focuses on the design and synthesis of conformationally constrained compounds that hold great potential for treating various diseases.
Latest Patents
Among Oumouch's latest patents are groundbreaking conformationally constrained, fully synthetic macrocyclic compounds. These compounds are characterized by a unique ring system that consists of three distinct molecular parts: Template A, conformation Modulator B, and Bridge C. They are synthesized using methods such as parallel synthesis or combinatorial chemistry, which allows for efficient production in solution or on solid phase. These macrocycles are engineered to interact with a range of biological targets, displaying properties that include agonistic or antagonistic activity on G-protein coupled receptors (GPCRs) and inhibitory activity on specific enzymes. Notably, they demonstrate inhibition of endothelin converting enzyme of subtype 1 (ECE-1), and act as antagonists of the oxytocin receptor, thyrotropin-releasing hormone receptor, and leukotriene B4 receptor, among others. Additionally, these compounds exhibit antimicrobial activity against various bacterial strains, highlighting their potential as novel medicaments for the treatment of diverse diseases.
Oumouch's research also includes conformationally constrained macrocyclic ring systems of 12-30 members that include an aromatic template, a conformational modulator, and a spacer moiety. These innovative compounds show significant promise for addressing gastrointestinal motility disorders, central nervous system diseases, and ocular hypertension associated with glaucoma.
Career Highlights
Said Oumouch holds a prominent position at Polyphor AG, where his research contributes to advancing therapeutic options in medicine. His portfolio of patents reflects not only his creativity but also his commitment to providing solutions for complex health challenges faced by patients worldwide.
Collaborations
Throughout his career, Oumouch has collaborated with talented colleagues such as Daniel Obrecht and Philipp Ermert. Together, these innovators work towards maximizing the potential of their research, aiming to bring new treatments to the forefront of medical science.
Conclusion
With his focus on synthetic compounds and their applications in medicine, inventor Said Oumouch stands at the forefront of pharmaceutical innovation. His contributions through patents and collaborative efforts continue to pave the way for advancements in health care, offering hope for treatments of various diseases and improving patient outcomes.